History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Cycle for Survival Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Newly Diagnosed?
We Can Help
Newly Diagnosed? We Can Help
Getting the correct diagnosis and the most appropriate treatment from the start is crucial

Biopsy

If a man's PSA level is elevated and digital rectal exam is abnormal, his physician is likely to suggest a biopsy. This is a procedure in which tissue samples are removed from the prostate and then examined by a pathologist. A biopsy can be performed in a urologist's office. Using a transrectal ultrasound (TRUS) probe, a physician can see the prostate and precisely place the biopsy needles to remove tissue from several different spots in the gland. Because the needles are inserted for only a fraction of a second, the procedure is essentially painless and takes about 20 minutes. During a standard biopsy, a physician removes six tissue samples. Researchers here are investigating ways to improve tissue sampling without using more needles.

If the results of the biopsy indicate that you do have prostate cancer, your physician will gather more information to further characterize the cancer and help determine the most effective course of treatment. In some cases, the physician may perform a second set of prostate biopsies for this purpose.

Gleason Grading System

Physicians characterize the aggressiveness of prostate cancer using the Gleason grading system, which provides an estimate of the cancer's potential to grow and spread to other parts of the body. The pathologist determines the Gleason grade based on how closely the cells of the gland resemble those of a normal prostate. A tumor whose cellular structure is close to normal is unlikely to be aggressively malignant and to spread -- and will be assigned a low combined Gleason score -- whereas a tumor that has little resemblance to a normal prostate is more likely to be aggressive and spread outside the prostate and will receive a high combined Gleason score (greater than or equal to 7.0). Memorial Sloan-Kettering's pathologists have an exceptional depth of expertise in analyzing prostate samples, and their skill is key in helping the other members of the prostate care team determine the most effective course of treatment for each patient.

Treatment is usually recommended for high-grade cancers, while observation may be recommended for low-grade cancers, especially when the patient is elderly or has other medical conditions.

Diagnostic Imaging

CancerSmart Web Cast
CancerSmart Web Cast
Our experts -- Drs. James Eastham, Michael Zelefsky, and Michael Morris -- discuss the screening, diagnosis, and treatment of prostate cancer

Physicians may also perform various imaging tests to determine the extent of the tumor in the prostate and whether cancer cells have spread to surrounding tissues or other parts of the body. Depending on the findings of the DRE, and the patient's PSA level and Gleason score, these tests may include:

  • ultrasound
  • microspectroscopy, a sophisticated chemical analysis, to better define the extent and location of a cancer
  • magnetic resonance imaging (MRI) using an endorectal or surface coil to help assess the extent of the tumor in the prostate and surrounding tissues
  • computed tomography (CT) scans or radionuclide bone scans to see if the disease has spread to lymph nodes, organs, or bones
  • positron emission tomography (PET), a technique under investigation here, to assess the extent of prostate cancer and particular features of its biology, such as whether it is responsive to antitestosterone agents

In some cases, no scans are necessary because the chance that cancer has spread is very low.

Researchers at Memorial Sloan-Kettering are investigating new imaging techniques that would better characterize each individual's cancer -- to gauge how his disease might respond to various treatment modalities and to determine, during treatment, whether and to what extent a specific treatment is effective.


Last Updated: Dec. 9, 2005
PrintEmail This Page